|
|
||||||||
Faculdade de Odontologia and Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo, 14040-904 Ribeirão Preto, Brazil
Hypoxia causes a regulated
decrease in body temperature
(Tb), and nitric oxide (NO) is
now known to participate in hypoxia-induced hypothermia.
Hypoxia also inhibits lipopolysaccharide (LPS)-induced fever. We tested
the hypothesis that NO may participate in the hypoxia inhibition of
fever. The rectal temperature of awake, unrestrained rats was measured
before and after injection of LPS, with or without concomitant exposure
to hypoxia, in an experimental group treated with
N
-nitro-L-arginine
(L-NNA) for 4 consecutive days
before the experiment and in a saline-treated group (control).
L-NNA is a nonspecific NO
synthase inhibitor that blocks NO production. LPS caused a dose-dependent typical biphasic rise in
Tb that was completely prevented
by hypoxia (7% inspired oxygen).
L-NNA caused a significant drop
in Tb during days
2-4 of treatment. When LPS was injected into
L-NNA-treated rats, inhibition
of fever was observed. Moreover, the effect of hypoxia during fever was
significantly reduced. The data indicate that the NO pathway plays a
role in hypoxia inhibition of fever.
endothelium-derived relaxing factor; temperature; nitric oxide synthase; lipopolysaccharide
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |